Instrumento Inactivo

Acciones Trivascular Technologies Inc

Acciones

Precio de cierre Nasdaq Otros sitios de cotización
- ^USD	-

TriVascular Technologies, Inc. Reports Third Quarter Financial Results	09/11/15
Preliminary Results of the LIFE Study Presented at VIVA 2015	03/11/15
Four-Year Results From Global Ovation Pivotal Trial Presented at VIVA 2015	03/11/15
Trivascular Technologies : Brower Piven Commences An Investigation Into The Proposed Sale Of TriVascular Technologies, Inc. And Encourages Investors To Contact The Firm For Additional Information	29/10/15
TRIVASCULAR TECHNOLOGIES : Former SEC Attorney Willie Briscoe and Powers Taylor LLP Believe the Acquisition by Endologix, Inc. May be Unfair to Shareholders	28/10/15

Directores	Puesto	Edad	Desde
John Onopchenko CEO	Chief Executive Officer	66	-
Vaseem Mahboob DFI	Director of Finance/CFO	55	03/02/16

Sector

	Varia. 1 de ene.	Capi.
SMITH & NEPHEW PLC	-7,58 %	10,74 mil M
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.	+2,17 %	8925,93 M
INSPIRE MEDICAL SYSTEMS, INC.	+22,75 %	7610,38 M
GLAUKOS CORPORATION	+33,99 %	5268,34 M
AXONICS, INC.	+8,12 %	3423,85 M
ENOVIS CORPORATION	-8,48 %	2858,83 M
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD.	-5,07 %	2230,54 M
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.	-4,22 %	2130,44 M
DOUBLE MEDICAL TECHNOLOGY INC.	-20,87 %	1837,09 M